Comparison of Insulin Glargine and Detemir on Hormone Factors Affecting Appetite in Patients with Type 1 Diabetes
Phase 3
- Conditions
- Type 1 Diabetes.Type 1 Diabetes mellitus
- Registration Number
- IRCT20191208045651N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Parent's Consent
new cases of children with type1 diabetes
Children under 18 years old.
Exclusion Criteria
No Parental consent
Non-cooperation until the end of the study (Discontinuation of use)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increase or decrease in Leptin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in Gherlin hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in AGRP hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).;Increase or decrease in PYY 3-36 hormone. Timepoint: before taking Insulin and 3 months after taking it. Method of measurement: Laboratory Test (Appetite hormones test).
- Secondary Outcome Measures
Name Time Method